Diagnostics

  • Trilis Bioscience

    Website Trilis Bioscience is developing a next-generation molecular detection platform that moves beyond conventional protein quantification by directly measuring functionally relevant post-translational modifications (PTMs) on specific protein targets within a single assay. Our proprietary co-recognition proximity architecture integrates AI-enabled minibinder engineering with oligonucleotide-based molecular logic to achieve highly specific, scalable, and multiplexed detection at the…

  • Exsera BioLabs

    Website Exsera BioLabs is a CAP/CLIA-certified niche laboratory specializing in autoimmune and complement testing, all conducted in compliance with FDA GxPs. They provide esoteric testing to support diagnostics and biomarker translation, with a strong focus on both autoimmune diseases and complement-related conditions. Their collaborations with researchers, biotech, and pharmaceutical companies help advance scientific discoveries and…

  • Cobio Diagnostics

    Website Cobio Diagnostics is a life sciences biotechnology company dedicated to the development and commercialization of rapid, next-generation, phage-amplified diagnostics for bacterial ID and phenotypic detection of antibiotic resistance.  

  • aiGENE

    Website Rapid, inexpensive, universal, on-site, pan-cancer monitoring of therapy effectiveness; ultimately an inexpensive, universal, pan-cancer screening test. Early identification of hyper-progressive disease or any inactive therapy and switching to an effective therapy can be lifesaving!

  • Starlyte Bio

    Website Starlyte Bio aims to push diagnostic technology into the next generation by illuminating the whole picture across diseases using the full chromatin structure that defines the disease state. This will provide insights into health and disease like never before.

  • Vega Surgical

    Website Vega Surgical combines the efficacy of the operating room with the efficiency of a bedside procedure, significantly decreasing cost and, more importantly, improving patient outcomes. Vega will treat what will soon be the most common cranial neurosurgical disorder, Chronic Subdural Hematomas (CSDH), with the Xcape port and Axis Drill. Today, CSDHs are treated in…

  • Vitan-Biotech LLC

    Website Vitan-Biotech specializes in the development and commercialization of breakthrough life science instrumentation, novel biosensing systems, and diagnostic devices. Vitan is developing novel cancer diagnostic devices, platforms for glycan biomarker discovery, and disposable biosensors for pathogen detection, including assay development services: Biochips for detecting multiple serum cytokines and cancer biomarkers; Point-of-care devices for Circulating Tumor…